Related Experiment Videos
The ligands/activators for peroxisome proliferator-activated receptor alpha (PPARalpha) and PPARgamma increase
1Fourth Department of Medicine, Saitama Medical School, Japan.
Metabolism: Clinical and Experimental
|February 15, 2001
Summary
Peroxisome proliferator-activated receptors (PPARs) influence antioxidant enzymes in endothelial cells. PPAR activation increases superoxide dismutase and decreases NADPH oxidase, suggesting a role in radical scavenging.
Area of Science:
- Endothelial cell biology
- Molecular pharmacology
- Oxidative stress research
Background:
- Endothelial cells play a crucial role in vascular health.
- Oxidative stress, mediated by enzymes like NADPH oxidase, contributes to endothelial dysfunction.
- Peroxisome proliferator-activated receptors (PPARs) are nuclear receptors involved in various cellular processes.
Purpose of the Study:
- To investigate the impact of peroxisome proliferator-activated receptor (PPAR) ligands on antioxidant and pro-oxidant enzyme expression in human endothelial cells.
- To determine the specific roles of PPARalpha and PPARgamma in regulating Cu2+,Zn2+-superoxide dismutase (CuZn-SOD) and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase.
Main Methods:
- Primary cultures of human umbilical vein endothelial cells (HUVEC) and human aorta endothelial cells (HAEC) were utilized.
- Cells were treated with various PPAR ligands/activators, including bezafibrate, troglitazone, and pioglitazone.
- Gene and protein expression levels of CuZn-SOD, NADPH oxidase subunits (p22phox, p47phox), and PPARs were analyzed.
Main Results:
- PPARalpha, PPARbeta/delta/Nuc1, and PPARgamma were detected in endothelial cells.
- PPARalpha activation (bezafibrate) increased CuZn-SOD expression.
- PPARgamma activation (troglitazone, pioglitazone) upregulated PPARalpha and CuZn-SOD expression.
- Fatty acid treatment showed a positive correlation between CuZn-SOD and PPARalpha mRNA levels.
- PPARalpha and PPARgamma activators reduced NADPH oxidase subunit expression (p22phox, p47phox).
Conclusions:
- PPARalpha and PPARgamma are expressed in endothelial cells and modulate key enzymes involved in oxidative stress.
- Activation of PPARalpha and PPARgamma enhances antioxidant capacity by increasing CuZn-SOD.
- PPAR activation suppresses NADPH oxidase activity, potentially mitigating oxidative damage in endothelial cells.
- These findings suggest a physiological role for PPARs as radical scavengers in the endothelium.